The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review

Esophagogastric Junction

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Esophagogastric Junction


High impact information on Esophagogastric Junction


Chemical compound and disease context of Esophagogastric Junction


Biological context of Esophagogastric Junction


Anatomical context of Esophagogastric Junction


Associations of Esophagogastric Junction with chemical compounds


Gene context of Esophagogastric Junction


Analytical, diagnostic and therapeutic context of Esophagogastric Junction


  1. Prediction of response to preoperative chemotherapy in adenocarcinomas of the esophagogastric junction by metabolic imaging. Weber, W.A., Ott, K., Becker, K., Dittler, H.J., Helmberger, H., Avril, N.E., Meisetschläger, G., Busch, R., Siewert, J.R., Schwaiger, M., Fink, U. J. Clin. Oncol. (2001) [Pubmed]
  2. Concurrent chemotherapy and radiation therapy followed by transhiatal esophagectomy for local-regional cancer of the esophagus. Forastiere, A.A., Orringer, M.B., Perez-Tamayo, C., Urba, S.G., Husted, S., Takasugi, B.J., Zahurak, M. J. Clin. Oncol. (1990) [Pubmed]
  3. Colonization with cagA-positive Helicobacter pylori strains in intestinal metaplasia of the esophagus and the esophagogastric junction. Ackermark, P., Kuipers, E.J., Wolf, C., Breumelhof, R., Seldenrijk, C.A., Timmer, R., Segeren, K.C., Kusters, J.G., Smout, A.J. Am. J. Gastroenterol. (2003) [Pubmed]
  4. Vascular endothelial growth factor and basic fibroblast growth factor expression in esophageal adenocarcinoma and Barrett esophagus. Lord, R.V., Park, J.M., Wickramasinghe, K., DeMeester, S.R., Oberg, S., Salonga, D., Singer, J., Peters, J.H., Danenberg, K.D., Demeester, T.R., Danenberg, P.V. J. Thorac. Cardiovasc. Surg. (2003) [Pubmed]
  5. Clinical and surgical relevance of the progressive phases of intrathoracic migration of the gastroesophageal junction in gastroesophageal reflux disease. Mattioli, S., D'Ovidio, F., Di Simone, M.P., Bassi, F., Brusori, S., Pilotti, V., Felice, V., Ferruzzi, L., Guernelli, N. J. Thorac. Cardiovasc. Surg. (1998) [Pubmed]
  6. Improvement of gastroesophageal reflux symptoms after radiofrequency energy: a randomized, sham-controlled trial. Corley, D.A., Katz, P., Wo, J.M., Stefan, A., Patti, M., Rothstein, R., Edmundowicz, S., Kline, M., Mason, R., Wolfe, M.M. Gastroenterology (2003) [Pubmed]
  7. Dietary nitrate generates potentially mutagenic concentrations of nitric oxide at the gastroesophageal junction. Iijima, K., Henry, E., Moriya, A., Wirz, A., Kelman, A.W., McColl, K.E. Gastroenterology (2002) [Pubmed]
  8. The mechanism of action of gastrin on the lower esophageal sphincter. Rattan, S., Coln, D., Goyal, R.K. Gastroenterology (1976) [Pubmed]
  9. Intensive preoperative chemotherapy with colony-stimulating factor for resectable adenocarcinoma of the esophagus or gastroesophageal junction. Ajani, J.A., Roth, J.A., Ryan, M.B., Putnam, J.B., Pazdur, R., Levin, B., Gutterman, J.U., McMurtrey, M. J. Clin. Oncol. (1993) [Pubmed]
  10. Docetaxel and capecitabine in patients with metastatic adenocarcinoma of the stomach and gastroesophageal junction: a phase II study from the North Central Cancer Treatment Group. Giordano, K.F., Jatoi, A., Stella, P.J., Foster, N., Tschetter, L.K., Alberts, S.R., Dakhil, S.R., Mailliard, J.A., Flynn, P.J., Nikcevich, D.A. Ann. Oncol. (2006) [Pubmed]
  11. Oxaliplatin and capecitabine in patients with metastatic adenocarcinoma of the esophagus, gastroesophageal junction and gastric cardia: a phase II study from the North Central Cancer Treatment Group. Jatoi, A., Murphy, B.R., Foster, N.R., Nikcevich, D.A., Alberts, S.R., Knost, J.A., Fitch, T.R., Rowland, K.M. Ann. Oncol. (2006) [Pubmed]
  12. Vicryl-scarf-induced scarring around esophagogastric junction as treatment of esophageal reflux disease. An experimental study in the dog. Feussner, H., Horvath, O.P., Siewert, J.R. Dig. Dis. Sci. (1992) [Pubmed]
  13. Alleviation of excessive gas accumulation in the ruminant stomach by ritanserin. Ruckebusch, Y., Ooms, L.A., Degryse, A.D., Allal, C. Am. J. Vet. Res. (1985) [Pubmed]
  14. Angelchik antireflux device: computed tomography appearance. Sussman, S.K., Illescas, F.F., Woodruff, W.W., Cooper, C. The Journal of computed tomography. (1987) [Pubmed]
  15. ING1 and p53 tumor suppressor gene alterations in adenocarcinomas of the esophagogastric junction. Hara, Y., Zheng, Z., Evans, S.C., Malatjalian, D., Riddell, D.C., Guernsey, D.L., Wang, L.D., Riabowol, K., Casson, A.G. Cancer Lett. (2003) [Pubmed]
  16. The presence and mucin histochemistry of cardiac type mucosa at the esophagogastric junction. Marsman, W.A., van Sandick, J.W., Tytgat, G.N., ten Kate, F.J., van Lanschot, J.J. Am. J. Gastroenterol. (2004) [Pubmed]
  17. A phase I/II study of external beam radiation, brachytherapy and concurrent chemotherapy in localized cancer of the esophagus (RTOG 92-07): preliminary toxicity report. Gaspar, L.E., Qian, C., Kocha, W.I., Coia, L.R., Herskovic, A., Graham, M. Int. J. Radiat. Oncol. Biol. Phys. (1997) [Pubmed]
  18. Phase I--II study of the combination of 5-FU, doxorubicin, mitomycin, and semustine (FAMMe) in the treatment of adenocarcinoma of the stomach, gastroesophageal junction, and pancreas. Karlin, D.A., Stroehlein, J.R., Bennetts, R.W., Jones, R.D., Heifetz, L.J., Mahal, P.S. Cancer treatment reports. (1982) [Pubmed]
  19. Control of variceal bleed by constricting esophageal sphincter with metoclopramide. Gupta, I.P., Sharma, M.P. Am. J. Gastroenterol. (1990) [Pubmed]
  20. Combination of folinic acid, 5-fluorouracil bolus and infusion, and cisplatin (LV5FU2-P regimen) in patients with advanced gastric or gastroesophageal junction carcinoma. Mitry, E., Taïeb, J., Artru, P., Boige, V., Vaillant, J.N., Clavero-Fabri, M.C., Ducreux, M., Rougier, P. Ann. Oncol. (2004) [Pubmed]
  21. Enhanced expression of interleukin-8 and activation of nuclear factor kappa-B in endoscopy-negative gastroesophageal reflux disease. Isomoto, H., Saenko, V.A., Kanazawa, Y., Nishi, Y., Ohtsuru, A., Inoue, K., Akazawa, Y., Takeshima, F., Omagari, K., Miyazaki, M., Mizuta, Y., Murata, I., Yamashita, S., Kohno, S. Am. J. Gastroenterol. (2004) [Pubmed]
  22. Complete 5-year follow-up of a prospective phase II trial of preoperative chemoradiotherapy for esophageal cancer. Posner, M.C., Gooding, W.E., Lew, J.I., Rosenstein, M.M., Lembersky, B.C. Surgery (2001) [Pubmed]
  23. Tachykinins in the canine gastroesophageal junction. Sandler, A.D., Maher, J.W., Weinstock, J.V., Schmidt, C.D., Schlegel, J.F., Jew, J.Y., Williams, T.H. Am. J. Surg. (1991) [Pubmed]
  24. Inhibition of telomerase by site-specific ribonucleases in gastric and esophageal adenocarcinoma. Usselmann, B., Portsmouth, D., Barclay, J., Morris, A.G., Nwokolo, C.U. Dig. Dis. Sci. (2001) [Pubmed]
  25. Identical cytokeratin expression pattern CK7+/CK20- in esophageal and cardiac cancer: etiopathological and clinical implications. Driessen, A., Nafteux, P., Lerut, T., Raemdonck, D.V., De Leyn, P., Filez, L., Penninckx, F., Geboes, K., Ectors, N. Mod. Pathol. (2004) [Pubmed]
  26. Retinoic acid receptor-alpha messenger RNA expression is increased and retinoic acid receptor-gamma expression is decreased in Barrett's intestinal metaplasia, dysplasia, adenocarcinoma sequence. Lord, R.V., Tsai, P.I., Danenberg, K.D., Peters, J.H., Demeester, T.R., Tsao-Wei, D.D., Groshen, S., Salonga, D., Park, J.M., Crookes, P.F., Kiyabu, M., Chandrasoma, P., Danenberg, P.V. Surgery (2001) [Pubmed]
  27. Three-field lymphadenectomy for carcinoma of the esophagus and gastroesophageal junction in 174 R0 resections: impact on staging, disease-free survival, and outcome: a plea for adaptation of TNM classification in upper-half esophageal carcinoma. Lerut, T., Nafteux, P., Moons, J., Coosemans, W., Decker, G., De Leyn, P., Van Raemdonck, D., Ectors, N. Ann. Surg. (2004) [Pubmed]
  28. Sleeve sensor versus high-resolution manometry for the detection of transient lower esophageal sphincter relaxations. Bredenoord, A.J., Weusten, B.L., Timmer, R., Smout, A.J. Am. J. Physiol. Gastrointest. Liver Physiol. (2005) [Pubmed]
  29. Promoter hypermethylation of p16INK4a, E-cadherin, O6-MGMT, DAPK and FHIT in adenocarcinomas of the esophagus, esophagogastric junction and proximal stomach. Schildhaus, H.U., Kröckel, I., Lippert, H., Malfertheiner, P., Roessner, A., Schneider-Stock, R. Int. J. Oncol. (2005) [Pubmed]
  30. Influence of breast versus formula milk on physiological gastroesophageal reflux in healthy, newborn infants. Heacock, H.J., Jeffery, H.E., Baker, J.L., Page, M. J. Pediatr. Gastroenterol. Nutr. (1992) [Pubmed]
  31. Endoscopic sclerotherapy in porcine esophagus changes luminal cross-sectional area and wall distensibility dose- and time-dependently. Petersen, J.A., Djurhuus, C., Koff, J., Vinter-Jensen, L., Gregersen, H. Dig. Dis. Sci. (1998) [Pubmed]
WikiGenes - Universities